Global Intravenous Immunoglobulin (IVIg) Market Growth 2026-2032
The global Intravenous Immunoglobulin (IVIg) market size is predicted to grow from US$ 19321 million in 2025 to US$ 32754 million in 2032; it is expected to grow at a CAGR of 7.9% from 2026 to 2032.
Intravenous Immunoglobulin (IVIg) is a highly purified immunoglobulin preparation derived from pooled human plasma, produced through cold ethanol fractionation, chromatographic purification, and validated viral inactivation processes. The primary component is polyclonal IgG antibodies. IVIg exerts therapeutic effects by supplementing humoral immunity and modulating immune responses. It is widely used in primary immunodeficiency diseases, autoimmune disorders, neurological conditions, and inflammatory diseases. Its mechanisms include pathogen neutralization, Fc receptor modulation, suppression of autoantibodies, and cytokine regulation. As a premium blood-derived product, IVIg plays an indispensable role in critical care and long-term management of immune-related disorders.In 2025, global Intravenous Immunoglobulin production reached approximately 164.59 million units and price is about 120 USD/Unit.The average gross profit margin of this product is 60%.
Rising diagnosis rates of primary immunodeficiency diseases and increasing prevalence of autoimmune disorders provide long-term demand growth for IVIg. Expansion into neurological indications and rare disease therapies continues to broaden clinical applications. Aging populations and the growing burden of chronic diseases further strengthen demand for immunomodulatory treatments. Expanded reimbursement coverage and regulatory standardization in the blood products sector support steady market expansion. Technological advancements that enhance purification efficiency and product safety also reinforce industry growth momentum.
IVIg production heavily depends on human plasma resources, which are inherently constrained by donation systems, regulatory policies, and ethical considerations. The manufacturing process is complex, requiring stringent quality control and viral safety measures, leading to high operational costs. In some regions, pricing regulations or centralized procurement mechanisms may limit profit margins. Rapid development of novel biologics and targeted immune therapies could create substitution pressure in certain indications. In addition, fluctuations in global plasma supply chains may impact market stability.
Downstream demand is concentrated in tertiary hospitals, neurology specialty centers, immunology clinics, and rare disease treatment institutions. Clinical use is expanding from acute rescue therapy to long-term maintenance regimens. High-concentration formulations and subcutaneous alternatives are gradually penetrating the market, although IVIg remains dominant in acute and severe cases. Precision stratification and multidisciplinary treatment models are improving therapeutic value per patient. International markets increasingly prioritize products with high safety standards and superior purity profiles.
The core raw material for IVIg is plasma collected from healthy donors, with quality directly influencing product safety and efficacy. Plasma collection relies on established donation networks, strict screening systems, and compliant regulatory environments. Production requires separation reagents, chromatography resins, viral inactivation solvents, and single-use bioprocess consumables. As global competition for plasma resources intensifies, upstream supply assurance has become a critical competitive barrier. Cold chain logistics and batch release systems are also essential to ensuring stable and continuous product supply.
LP Information, Inc. (LPI) ' newest research report, the ?Intravenous Immunoglobulin (IVIg) Industry Forecast? looks at past sales and reviews total world Intravenous Immunoglobulin (IVIg) sales in 2025, providing a comprehensive analysis by region and market sector of projected Intravenous Immunoglobulin (IVIg) sales for 2026 through 2032. With Intravenous Immunoglobulin (IVIg) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Immunoglobulin (IVIg) industry.
This Insight Report provides a comprehensive analysis of the global Intravenous Immunoglobulin (IVIg) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Immunoglobulin (IVIg) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Intravenous Immunoglobulin (IVIg) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Immunoglobulin (IVIg) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Immunoglobulin (IVIg).
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Immunoglobulin (IVIg) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Intravenous Immunoglobulin (IVIg) market?
What factors are driving Intravenous Immunoglobulin (IVIg) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravenous Immunoglobulin (IVIg) market opportunities vary by end market size?
How does Intravenous Immunoglobulin (IVIg) break out by Type, by Application?
Intravenous Immunoglobulin (IVIg) is a highly purified immunoglobulin preparation derived from pooled human plasma, produced through cold ethanol fractionation, chromatographic purification, and validated viral inactivation processes. The primary component is polyclonal IgG antibodies. IVIg exerts therapeutic effects by supplementing humoral immunity and modulating immune responses. It is widely used in primary immunodeficiency diseases, autoimmune disorders, neurological conditions, and inflammatory diseases. Its mechanisms include pathogen neutralization, Fc receptor modulation, suppression of autoantibodies, and cytokine regulation. As a premium blood-derived product, IVIg plays an indispensable role in critical care and long-term management of immune-related disorders.In 2025, global Intravenous Immunoglobulin production reached approximately 164.59 million units and price is about 120 USD/Unit.The average gross profit margin of this product is 60%.
Rising diagnosis rates of primary immunodeficiency diseases and increasing prevalence of autoimmune disorders provide long-term demand growth for IVIg. Expansion into neurological indications and rare disease therapies continues to broaden clinical applications. Aging populations and the growing burden of chronic diseases further strengthen demand for immunomodulatory treatments. Expanded reimbursement coverage and regulatory standardization in the blood products sector support steady market expansion. Technological advancements that enhance purification efficiency and product safety also reinforce industry growth momentum.
IVIg production heavily depends on human plasma resources, which are inherently constrained by donation systems, regulatory policies, and ethical considerations. The manufacturing process is complex, requiring stringent quality control and viral safety measures, leading to high operational costs. In some regions, pricing regulations or centralized procurement mechanisms may limit profit margins. Rapid development of novel biologics and targeted immune therapies could create substitution pressure in certain indications. In addition, fluctuations in global plasma supply chains may impact market stability.
Downstream demand is concentrated in tertiary hospitals, neurology specialty centers, immunology clinics, and rare disease treatment institutions. Clinical use is expanding from acute rescue therapy to long-term maintenance regimens. High-concentration formulations and subcutaneous alternatives are gradually penetrating the market, although IVIg remains dominant in acute and severe cases. Precision stratification and multidisciplinary treatment models are improving therapeutic value per patient. International markets increasingly prioritize products with high safety standards and superior purity profiles.
The core raw material for IVIg is plasma collected from healthy donors, with quality directly influencing product safety and efficacy. Plasma collection relies on established donation networks, strict screening systems, and compliant regulatory environments. Production requires separation reagents, chromatography resins, viral inactivation solvents, and single-use bioprocess consumables. As global competition for plasma resources intensifies, upstream supply assurance has become a critical competitive barrier. Cold chain logistics and batch release systems are also essential to ensuring stable and continuous product supply.
LP Information, Inc. (LPI) ' newest research report, the ?Intravenous Immunoglobulin (IVIg) Industry Forecast? looks at past sales and reviews total world Intravenous Immunoglobulin (IVIg) sales in 2025, providing a comprehensive analysis by region and market sector of projected Intravenous Immunoglobulin (IVIg) sales for 2026 through 2032. With Intravenous Immunoglobulin (IVIg) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Immunoglobulin (IVIg) industry.
This Insight Report provides a comprehensive analysis of the global Intravenous Immunoglobulin (IVIg) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Immunoglobulin (IVIg) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Intravenous Immunoglobulin (IVIg) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Immunoglobulin (IVIg) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Immunoglobulin (IVIg).
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Immunoglobulin (IVIg) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- IVIg Liquid
- IVIg Powder
- Low Concentration
- Medium Concentration
- High Concentration
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
What is the 10-year outlook for the global Intravenous Immunoglobulin (IVIg) market?
What factors are driving Intravenous Immunoglobulin (IVIg) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravenous Immunoglobulin (IVIg) market opportunities vary by end market size?
How does Intravenous Immunoglobulin (IVIg) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravenous Immunoglobulin (IVIg) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Intravenous Immunoglobulin (IVIg) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Intravenous Immunoglobulin (IVIg) by Country/Region, 2021, 2025 & 2032
2.2 Intravenous Immunoglobulin (IVIg) Segment by Type
2.2.1 IVIg Liquid
2.2.2 IVIg Powder
2.2.3 Intravenous Immunoglobulin (IVIg) Sales by Type
2.2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2021-2026)
2.3 Intravenous Immunoglobulin (IVIg) Segment by Treatment Setting
2.3.1 Low Concentration
2.3.2 Medium Concentration
2.3.3 High Concentration
2.3.4 Intravenous Immunoglobulin (IVIg) Sales by Treatment Setting
2.3.4.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Treatment Setting (2021-2026)
2.3.4.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Treatment Setting (2021-2026)
2.3.4.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Treatment Setting (2021-2026)
2.4 Intravenous Immunoglobulin (IVIg) Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.4.4 Intravenous Immunoglobulin (IVIg) Sales by Application
2.4.4.1 Global Intravenous Immunoglobulin (IVIg) Sale Market Share by Application (2021-2026)
2.4.4.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Intravenous Immunoglobulin (IVIg) Breakdown Data by Company
3.1.1 Global Intravenous Immunoglobulin (IVIg) Annual Sales by Company (2021-2026)
3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2021-2026)
3.2 Global Intravenous Immunoglobulin (IVIg) Annual Revenue by Company (2021-2026)
3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2021-2026)
3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2021-2026)
3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Company
3.4 Key Manufacturers Intravenous Immunoglobulin (IVIg) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Immunoglobulin (IVIg) Product Location Distribution
3.4.2 Players Intravenous Immunoglobulin (IVIg) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INTRAVENOUS IMMUNOGLOBULIN (IVIG) BY GEOGRAPHIC REGION
4.1 World Historic Intravenous Immunoglobulin (IVIg) Market Size by Geographic Region (2021-2026)
4.1.1 Global Intravenous Immunoglobulin (IVIg) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Intravenous Immunoglobulin (IVIg) Market Size by Country/Region (2021-2026)
4.2.1 Global Intravenous Immunoglobulin (IVIg) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Intravenous Immunoglobulin (IVIg) Sales Growth
4.4 APAC Intravenous Immunoglobulin (IVIg) Sales Growth
4.5 Europe Intravenous Immunoglobulin (IVIg) Sales Growth
4.6 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Growth
5 AMERICAS
5.1 Americas Intravenous Immunoglobulin (IVIg) Sales by Country
5.1.1 Americas Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026)
5.1.2 Americas Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026)
5.2 Americas Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026)
5.3 Americas Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Immunoglobulin (IVIg) Sales by Region
6.1.1 APAC Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2026)
6.1.2 APAC Intravenous Immunoglobulin (IVIg) Revenue by Region (2021-2026)
6.2 APAC Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026)
6.3 APAC Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravenous Immunoglobulin (IVIg) by Country
7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026)
7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026)
7.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026)
7.3 Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) by Country
8.1.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026)
8.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026)
8.3 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin (IVIg)
10.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
10.4 Industry Chain Structure of Intravenous Immunoglobulin (IVIg)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous Immunoglobulin (IVIg) Distributors
11.3 Intravenous Immunoglobulin (IVIg) Customer
12 WORLD FORECAST REVIEW FOR INTRAVENOUS IMMUNOGLOBULIN (IVIG) BY GEOGRAPHIC REGION
12.1 Global Intravenous Immunoglobulin (IVIg) Market Size Forecast by Region
12.1.1 Global Intravenous Immunoglobulin (IVIg) Forecast by Region (2027-2032)
12.1.2 Global Intravenous Immunoglobulin (IVIg) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Intravenous Immunoglobulin (IVIg) Forecast by Type (2027-2032)
12.7 Global Intravenous Immunoglobulin (IVIg) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.1.3 Takeda Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.2.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.3.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Kedrion
13.5.1 Kedrion Company Information
13.5.2 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.5.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Kedrion Main Business Overview
13.5.5 Kedrion Latest Developments
13.6 LFB Group
13.6.1 LFB Group Company Information
13.6.2 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.6.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 LFB Group Main Business Overview
13.6.5 LFB Group Latest Developments
13.7 Biotest
13.7.1 Biotest Company Information
13.7.2 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.7.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Biotest Main Business Overview
13.7.5 Biotest Latest Developments
13.8 BPL
13.8.1 BPL Company Information
13.8.2 BPL Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.8.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BPL Main Business Overview
13.8.5 BPL Latest Developments
13.9 RAAS
13.9.1 RAAS Company Information
13.9.2 RAAS Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.9.3 RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 RAAS Main Business Overview
13.9.5 RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 Hualan Bio
13.11.1 Hualan Bio Company Information
13.11.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.11.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hualan Bio Main Business Overview
13.11.5 Hualan Bio Latest Developments
13.12 Tiantan Bio
13.12.1 Tiantan Bio Company Information
13.12.2 Tiantan Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.12.3 Tiantan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Tiantan Bio Main Business Overview
13.12.5 Tiantan Bio Latest Developments
13.13 Shuanglin Bio
13.13.1 Shuanglin Bio Company Information
13.13.2 Shuanglin Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.13.3 Shuanglin Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shuanglin Bio Main Business Overview
13.13.5 Shuanglin Bio Latest Developments
13.14 Boya Bio
13.14.1 Boya Bio Company Information
13.14.2 Boya Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.14.3 Boya Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Boya Bio Main Business Overview
13.14.5 Boya Bio Latest Developments
13.15 Yuanda Shuyang
13.15.1 Yuanda Shuyang Company Information
13.15.2 Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.15.3 Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Yuanda Shuyang Main Business Overview
13.15.5 Yuanda Shuyang Latest Developments
13.16 Weiguang Bio
13.16.1 Weiguang Bio Company Information
13.16.2 Weiguang Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.16.3 Weiguang Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Weiguang Bio Main Business Overview
13.16.5 Weiguang Bio Latest Developments
13.17 Nanyue Bio
13.17.1 Nanyue Bio Company Information
13.17.2 Nanyue Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.17.3 Nanyue Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Nanyue Bio Main Business Overview
13.17.5 Nanyue Bio Latest Developments
13.18 KM Biologics
13.18.1 KM Biologics Company Information
13.18.2 KM Biologics Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.18.3 KM Biologics Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 KM Biologics Main Business Overview
13.18.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravenous Immunoglobulin (IVIg) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Intravenous Immunoglobulin (IVIg) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Intravenous Immunoglobulin (IVIg) by Country/Region, 2021, 2025 & 2032
2.2 Intravenous Immunoglobulin (IVIg) Segment by Type
2.2.1 IVIg Liquid
2.2.2 IVIg Powder
2.2.3 Intravenous Immunoglobulin (IVIg) Sales by Type
2.2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2021-2026)
2.3 Intravenous Immunoglobulin (IVIg) Segment by Treatment Setting
2.3.1 Low Concentration
2.3.2 Medium Concentration
2.3.3 High Concentration
2.3.4 Intravenous Immunoglobulin (IVIg) Sales by Treatment Setting
2.3.4.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Treatment Setting (2021-2026)
2.3.4.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Treatment Setting (2021-2026)
2.3.4.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Treatment Setting (2021-2026)
2.4 Intravenous Immunoglobulin (IVIg) Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.4.4 Intravenous Immunoglobulin (IVIg) Sales by Application
2.4.4.1 Global Intravenous Immunoglobulin (IVIg) Sale Market Share by Application (2021-2026)
2.4.4.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Intravenous Immunoglobulin (IVIg) Breakdown Data by Company
3.1.1 Global Intravenous Immunoglobulin (IVIg) Annual Sales by Company (2021-2026)
3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2021-2026)
3.2 Global Intravenous Immunoglobulin (IVIg) Annual Revenue by Company (2021-2026)
3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2021-2026)
3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2021-2026)
3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Company
3.4 Key Manufacturers Intravenous Immunoglobulin (IVIg) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Immunoglobulin (IVIg) Product Location Distribution
3.4.2 Players Intravenous Immunoglobulin (IVIg) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INTRAVENOUS IMMUNOGLOBULIN (IVIG) BY GEOGRAPHIC REGION
4.1 World Historic Intravenous Immunoglobulin (IVIg) Market Size by Geographic Region (2021-2026)
4.1.1 Global Intravenous Immunoglobulin (IVIg) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Intravenous Immunoglobulin (IVIg) Market Size by Country/Region (2021-2026)
4.2.1 Global Intravenous Immunoglobulin (IVIg) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Intravenous Immunoglobulin (IVIg) Sales Growth
4.4 APAC Intravenous Immunoglobulin (IVIg) Sales Growth
4.5 Europe Intravenous Immunoglobulin (IVIg) Sales Growth
4.6 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Growth
5 AMERICAS
5.1 Americas Intravenous Immunoglobulin (IVIg) Sales by Country
5.1.1 Americas Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026)
5.1.2 Americas Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026)
5.2 Americas Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026)
5.3 Americas Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Immunoglobulin (IVIg) Sales by Region
6.1.1 APAC Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2026)
6.1.2 APAC Intravenous Immunoglobulin (IVIg) Revenue by Region (2021-2026)
6.2 APAC Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026)
6.3 APAC Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravenous Immunoglobulin (IVIg) by Country
7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026)
7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026)
7.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026)
7.3 Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) by Country
8.1.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026)
8.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026)
8.3 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin (IVIg)
10.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
10.4 Industry Chain Structure of Intravenous Immunoglobulin (IVIg)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous Immunoglobulin (IVIg) Distributors
11.3 Intravenous Immunoglobulin (IVIg) Customer
12 WORLD FORECAST REVIEW FOR INTRAVENOUS IMMUNOGLOBULIN (IVIG) BY GEOGRAPHIC REGION
12.1 Global Intravenous Immunoglobulin (IVIg) Market Size Forecast by Region
12.1.1 Global Intravenous Immunoglobulin (IVIg) Forecast by Region (2027-2032)
12.1.2 Global Intravenous Immunoglobulin (IVIg) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Intravenous Immunoglobulin (IVIg) Forecast by Type (2027-2032)
12.7 Global Intravenous Immunoglobulin (IVIg) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.1.3 Takeda Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.2.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.3.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Kedrion
13.5.1 Kedrion Company Information
13.5.2 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.5.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Kedrion Main Business Overview
13.5.5 Kedrion Latest Developments
13.6 LFB Group
13.6.1 LFB Group Company Information
13.6.2 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.6.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 LFB Group Main Business Overview
13.6.5 LFB Group Latest Developments
13.7 Biotest
13.7.1 Biotest Company Information
13.7.2 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.7.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Biotest Main Business Overview
13.7.5 Biotest Latest Developments
13.8 BPL
13.8.1 BPL Company Information
13.8.2 BPL Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.8.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BPL Main Business Overview
13.8.5 BPL Latest Developments
13.9 RAAS
13.9.1 RAAS Company Information
13.9.2 RAAS Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.9.3 RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 RAAS Main Business Overview
13.9.5 RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 Hualan Bio
13.11.1 Hualan Bio Company Information
13.11.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.11.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hualan Bio Main Business Overview
13.11.5 Hualan Bio Latest Developments
13.12 Tiantan Bio
13.12.1 Tiantan Bio Company Information
13.12.2 Tiantan Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.12.3 Tiantan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Tiantan Bio Main Business Overview
13.12.5 Tiantan Bio Latest Developments
13.13 Shuanglin Bio
13.13.1 Shuanglin Bio Company Information
13.13.2 Shuanglin Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.13.3 Shuanglin Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shuanglin Bio Main Business Overview
13.13.5 Shuanglin Bio Latest Developments
13.14 Boya Bio
13.14.1 Boya Bio Company Information
13.14.2 Boya Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.14.3 Boya Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Boya Bio Main Business Overview
13.14.5 Boya Bio Latest Developments
13.15 Yuanda Shuyang
13.15.1 Yuanda Shuyang Company Information
13.15.2 Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.15.3 Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Yuanda Shuyang Main Business Overview
13.15.5 Yuanda Shuyang Latest Developments
13.16 Weiguang Bio
13.16.1 Weiguang Bio Company Information
13.16.2 Weiguang Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.16.3 Weiguang Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Weiguang Bio Main Business Overview
13.16.5 Weiguang Bio Latest Developments
13.17 Nanyue Bio
13.17.1 Nanyue Bio Company Information
13.17.2 Nanyue Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.17.3 Nanyue Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Nanyue Bio Main Business Overview
13.17.5 Nanyue Bio Latest Developments
13.18 KM Biologics
13.18.1 KM Biologics Company Information
13.18.2 KM Biologics Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
13.18.3 KM Biologics Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 KM Biologics Main Business Overview
13.18.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Intravenous Immunoglobulin (IVIg) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Intravenous Immunoglobulin (IVIg) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of IVIg Liquid
Table 4. Major Players of IVIg Powder
Table 5. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle)
Table 6. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026)
Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2021-2026)
Table 9. Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2021-2026) & (USD/Bottle)
Table 10. Major Players of Low Concentration
Table 11. Major Players of Medium Concentration
Table 12. Major Players of High Concentration
Table 13. Global Intravenous Immunoglobulin (IVIg) Sales by Treatment Setting (2021-2026) & (K Bottle)
Table 14. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Treatment Setting (2021-2026)
Table 15. Global Intravenous Immunoglobulin (IVIg) Revenue by Treatment Setting (2021-2026) & ($ million)
Table 16. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Treatment Setting (2021-2026)
Table 17. Global Intravenous Immunoglobulin (IVIg) Sale Price by Treatment Setting (2021-2026) & (USD/Bottle)
Table 18. Major Players of Acute Therapy
Table 19. Major Players of Maintenance Therapy
Table 20. Major Players of Critical Care
Table 21. Global Intravenous Immunoglobulin (IVIg) Sale by Application (2021-2026) & (K Bottle)
Table 22. Global Intravenous Immunoglobulin (IVIg) Sale Market Share by Application (2021-2026)
Table 23. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2026) & ($ million)
Table 24. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2021-2026)
Table 25. Global Intravenous Immunoglobulin (IVIg) Sale Price by Application (2021-2026) & (USD/Bottle)
Table 26. Global Intravenous Immunoglobulin (IVIg) Sales by Company (2021-2026) & (K Bottle)
Table 27. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2021-2026)
Table 28. Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2021-2026) & ($ millions)
Table 29. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2021-2026)
Table 30. Global Intravenous Immunoglobulin (IVIg) Sale Price by Company (2021-2026) & (USD/Bottle)
Table 31. Key Manufacturers Intravenous Immunoglobulin (IVIg) Producing Area Distribution and Sales Area
Table 32. Players Intravenous Immunoglobulin (IVIg) Products Offered
Table 33. Intravenous Immunoglobulin (IVIg) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 34. New Products and Potential Entrants
Table 35. Market M&A Activity & Strategy
Table 36. Global Intravenous Immunoglobulin (IVIg) Sales by Geographic Region (2021-2026) & (K Bottle)
Table 37. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Geographic Region (2021-2026)
Table 38. Global Intravenous Immunoglobulin (IVIg) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 39. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Geographic Region (2021-2026)
Table 40. Global Intravenous Immunoglobulin (IVIg) Sales by Country/Region (2021-2026) & (K Bottle)
Table 41. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Country/Region (2021-2026)
Table 42. Global Intravenous Immunoglobulin (IVIg) Revenue by Country/Region (2021-2026) & ($ millions)
Table 43. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country/Region (2021-2026)
Table 44. Americas Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle)
Table 45. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2026)
Table 46. Americas Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026) & ($ millions)
Table 47. Americas Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle)
Table 48. Americas Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle)
Table 49. APAC Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2026) & (K Bottle)
Table 50. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2021-2026)
Table 51. APAC Intravenous Immunoglobulin (IVIg) Revenue by Region (2021-2026) & ($ millions)
Table 52. APAC Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle)
Table 53. APAC Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle)
Table 54. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle)
Table 55. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026) & ($ millions)
Table 56. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle)
Table 57. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle)
Table 58. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle)
Table 59. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2021-2026)
Table 60. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle)
Table 61. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle)
Table 62. Key Market Drivers & Growth Opportunities of Intravenous Immunoglobulin (IVIg)
Table 63. Key Market Challenges & Risks of Intravenous Immunoglobulin (IVIg)
Table 64. Key Industry Trends of Intravenous Immunoglobulin (IVIg)
Table 65. Intravenous Immunoglobulin (IVIg) Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Intravenous Immunoglobulin (IVIg) Distributors List
Table 68. Intravenous Immunoglobulin (IVIg) Customer List
Table 69. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2027-2032) & (K Bottle)
Table 70. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 71. Americas Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032) & (K Bottle)
Table 72. Americas Intravenous Immunoglobulin (IVIg) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 73. APAC Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2027-2032) & (K Bottle)
Table 74. APAC Intravenous Immunoglobulin (IVIg) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Europe Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032) & (K Bottle)
Table 76. Europe Intravenous Immunoglobulin (IVIg) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032) & (K Bottle)
Table 78. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2027-2032) & (K Bottle)
Table 80. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 81. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2027-2032) & (K Bottle)
Table 82. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 83. Takeda Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 84. Takeda Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 85. Takeda Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 86. Takeda Main Business
Table 87. Takeda Latest Developments
Table 88. CSL Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 89. CSL Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 90. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 91. CSL Main Business
Table 92. CSL Latest Developments
Table 93. Grifols Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 94. Grifols Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 95. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 96. Grifols Main Business
Table 97. Grifols Latest Developments
Table 98. Octapharma Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 99. Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 100. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 101. Octapharma Main Business
Table 102. Octapharma Latest Developments
Table 103. Kedrion Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 104. Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 105. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 106. Kedrion Main Business
Table 107. Kedrion Latest Developments
Table 108. LFB Group Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 109. LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 110. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 111. LFB Group Main Business
Table 112. LFB Group Latest Developments
Table 113. Biotest Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 114. Biotest Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 115. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 116. Biotest Main Business
Table 117. Biotest Latest Developments
Table 118. BPL Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 119. BPL Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 120. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 121. BPL Main Business
Table 122. BPL Latest Developments
Table 123. RAAS Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 124. RAAS Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 125. RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 126. RAAS Main Business
Table 127. RAAS Latest Developments
Table 128. CBPO Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 129. CBPO Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 130. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 131. CBPO Main Business
Table 132. CBPO Latest Developments
Table 133. Hualan Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 134. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 135. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 136. Hualan Bio Main Business
Table 137. Hualan Bio Latest Developments
Table 138. Tiantan Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 139. Tiantan Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 140. Tiantan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 141. Tiantan Bio Main Business
Table 142. Tiantan Bio Latest Developments
Table 143. Shuanglin Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 144. Shuanglin Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 145. Shuanglin Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 146. Shuanglin Bio Main Business
Table 147. Shuanglin Bio Latest Developments
Table 148. Boya Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 149. Boya Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 150. Boya Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 151. Boya Bio Main Business
Table 152. Boya Bio Latest Developments
Table 153. Yuanda Shuyang Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 154. Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 155. Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 156. Yuanda Shuyang Main Business
Table 157. Yuanda Shuyang Latest Developments
Table 158. Weiguang Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 159. Weiguang Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 160. Weiguang Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 161. Weiguang Bio Main Business
Table 162. Weiguang Bio Latest Developments
Table 163. Nanyue Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 164. Nanyue Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 165. Nanyue Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 166. Nanyue Bio Main Business
Table 167. Nanyue Bio Latest Developments
Table 168. KM Biologics Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 169. KM Biologics Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 170. KM Biologics Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 171. KM Biologics Main Business
Table 172. KM Biologics Latest Developments
Table 1. Intravenous Immunoglobulin (IVIg) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Intravenous Immunoglobulin (IVIg) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of IVIg Liquid
Table 4. Major Players of IVIg Powder
Table 5. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle)
Table 6. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026)
Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2021-2026)
Table 9. Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2021-2026) & (USD/Bottle)
Table 10. Major Players of Low Concentration
Table 11. Major Players of Medium Concentration
Table 12. Major Players of High Concentration
Table 13. Global Intravenous Immunoglobulin (IVIg) Sales by Treatment Setting (2021-2026) & (K Bottle)
Table 14. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Treatment Setting (2021-2026)
Table 15. Global Intravenous Immunoglobulin (IVIg) Revenue by Treatment Setting (2021-2026) & ($ million)
Table 16. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Treatment Setting (2021-2026)
Table 17. Global Intravenous Immunoglobulin (IVIg) Sale Price by Treatment Setting (2021-2026) & (USD/Bottle)
Table 18. Major Players of Acute Therapy
Table 19. Major Players of Maintenance Therapy
Table 20. Major Players of Critical Care
Table 21. Global Intravenous Immunoglobulin (IVIg) Sale by Application (2021-2026) & (K Bottle)
Table 22. Global Intravenous Immunoglobulin (IVIg) Sale Market Share by Application (2021-2026)
Table 23. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2026) & ($ million)
Table 24. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2021-2026)
Table 25. Global Intravenous Immunoglobulin (IVIg) Sale Price by Application (2021-2026) & (USD/Bottle)
Table 26. Global Intravenous Immunoglobulin (IVIg) Sales by Company (2021-2026) & (K Bottle)
Table 27. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2021-2026)
Table 28. Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2021-2026) & ($ millions)
Table 29. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2021-2026)
Table 30. Global Intravenous Immunoglobulin (IVIg) Sale Price by Company (2021-2026) & (USD/Bottle)
Table 31. Key Manufacturers Intravenous Immunoglobulin (IVIg) Producing Area Distribution and Sales Area
Table 32. Players Intravenous Immunoglobulin (IVIg) Products Offered
Table 33. Intravenous Immunoglobulin (IVIg) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 34. New Products and Potential Entrants
Table 35. Market M&A Activity & Strategy
Table 36. Global Intravenous Immunoglobulin (IVIg) Sales by Geographic Region (2021-2026) & (K Bottle)
Table 37. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Geographic Region (2021-2026)
Table 38. Global Intravenous Immunoglobulin (IVIg) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 39. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Geographic Region (2021-2026)
Table 40. Global Intravenous Immunoglobulin (IVIg) Sales by Country/Region (2021-2026) & (K Bottle)
Table 41. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Country/Region (2021-2026)
Table 42. Global Intravenous Immunoglobulin (IVIg) Revenue by Country/Region (2021-2026) & ($ millions)
Table 43. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country/Region (2021-2026)
Table 44. Americas Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle)
Table 45. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2026)
Table 46. Americas Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026) & ($ millions)
Table 47. Americas Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle)
Table 48. Americas Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle)
Table 49. APAC Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2026) & (K Bottle)
Table 50. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2021-2026)
Table 51. APAC Intravenous Immunoglobulin (IVIg) Revenue by Region (2021-2026) & ($ millions)
Table 52. APAC Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle)
Table 53. APAC Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle)
Table 54. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle)
Table 55. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2021-2026) & ($ millions)
Table 56. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle)
Table 57. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle)
Table 58. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle)
Table 59. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2021-2026)
Table 60. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle)
Table 61. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle)
Table 62. Key Market Drivers & Growth Opportunities of Intravenous Immunoglobulin (IVIg)
Table 63. Key Market Challenges & Risks of Intravenous Immunoglobulin (IVIg)
Table 64. Key Industry Trends of Intravenous Immunoglobulin (IVIg)
Table 65. Intravenous Immunoglobulin (IVIg) Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Intravenous Immunoglobulin (IVIg) Distributors List
Table 68. Intravenous Immunoglobulin (IVIg) Customer List
Table 69. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2027-2032) & (K Bottle)
Table 70. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 71. Americas Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032) & (K Bottle)
Table 72. Americas Intravenous Immunoglobulin (IVIg) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 73. APAC Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2027-2032) & (K Bottle)
Table 74. APAC Intravenous Immunoglobulin (IVIg) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Europe Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032) & (K Bottle)
Table 76. Europe Intravenous Immunoglobulin (IVIg) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032) & (K Bottle)
Table 78. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2027-2032) & (K Bottle)
Table 80. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 81. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2027-2032) & (K Bottle)
Table 82. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 83. Takeda Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 84. Takeda Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 85. Takeda Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 86. Takeda Main Business
Table 87. Takeda Latest Developments
Table 88. CSL Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 89. CSL Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 90. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 91. CSL Main Business
Table 92. CSL Latest Developments
Table 93. Grifols Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 94. Grifols Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 95. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 96. Grifols Main Business
Table 97. Grifols Latest Developments
Table 98. Octapharma Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 99. Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 100. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 101. Octapharma Main Business
Table 102. Octapharma Latest Developments
Table 103. Kedrion Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 104. Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 105. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 106. Kedrion Main Business
Table 107. Kedrion Latest Developments
Table 108. LFB Group Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 109. LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 110. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 111. LFB Group Main Business
Table 112. LFB Group Latest Developments
Table 113. Biotest Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 114. Biotest Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 115. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 116. Biotest Main Business
Table 117. Biotest Latest Developments
Table 118. BPL Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 119. BPL Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 120. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 121. BPL Main Business
Table 122. BPL Latest Developments
Table 123. RAAS Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 124. RAAS Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 125. RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 126. RAAS Main Business
Table 127. RAAS Latest Developments
Table 128. CBPO Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 129. CBPO Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 130. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 131. CBPO Main Business
Table 132. CBPO Latest Developments
Table 133. Hualan Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 134. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 135. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 136. Hualan Bio Main Business
Table 137. Hualan Bio Latest Developments
Table 138. Tiantan Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 139. Tiantan Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 140. Tiantan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 141. Tiantan Bio Main Business
Table 142. Tiantan Bio Latest Developments
Table 143. Shuanglin Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 144. Shuanglin Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 145. Shuanglin Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 146. Shuanglin Bio Main Business
Table 147. Shuanglin Bio Latest Developments
Table 148. Boya Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 149. Boya Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 150. Boya Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 151. Boya Bio Main Business
Table 152. Boya Bio Latest Developments
Table 153. Yuanda Shuyang Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 154. Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 155. Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 156. Yuanda Shuyang Main Business
Table 157. Yuanda Shuyang Latest Developments
Table 158. Weiguang Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 159. Weiguang Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 160. Weiguang Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 161. Weiguang Bio Main Business
Table 162. Weiguang Bio Latest Developments
Table 163. Nanyue Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 164. Nanyue Bio Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 165. Nanyue Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 166. Nanyue Bio Main Business
Table 167. Nanyue Bio Latest Developments
Table 168. KM Biologics Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 169. KM Biologics Intravenous Immunoglobulin (IVIg) Product Portfolios and Specifications
Table 170. KM Biologics Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2021-2026)
Table 171. KM Biologics Main Business
Table 172. KM Biologics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Intravenous Immunoglobulin (IVIg)
Figure 2. Intravenous Immunoglobulin (IVIg) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate 2021-2032 (K Bottle)
Figure 7. Global Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Intravenous Immunoglobulin (IVIg) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Intravenous Immunoglobulin (IVIg) Sales Market Share by Country/Region (2025)
Figure 10. Intravenous Immunoglobulin (IVIg) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of IVIg Liquid
Figure 12. Product Picture of IVIg Powder
Figure 13. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2026
Figure 14. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Low Concentration
Figure 16. Product Picture of Medium Concentration
Figure 17. Product Picture of High Concentration
Figure 18. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Treatment Setting in 2026
Figure 19. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Treatment Setting (2021-2026)
Figure 20. Product Picture of Acute Therapy
Figure 21. Product Picture of Maintenance Therapy
Figure 22. Product Picture of Critical Care
Figure 23. Intravenous Immunoglobulin (IVIg) Consumed in Immunodeficiency
Figure 24. Global Intravenous Immunoglobulin (IVIg) Market: Immunodeficiency (2021-2026) & (K Bottle)
Figure 25. Intravenous Immunoglobulin (IVIg) Consumed in Autoimmune Disease
Figure 26. Global Intravenous Immunoglobulin (IVIg) Market: Autoimmune Disease (2021-2026) & (K Bottle)
Figure 27. Intravenous Immunoglobulin (IVIg) Consumed in Acute Infection
Figure 28. Global Intravenous Immunoglobulin (IVIg) Market: Acute Infection (2021-2026) & (K Bottle)
Figure 29. Global Intravenous Immunoglobulin (IVIg) Sale Market Share by Application (2025)
Figure 30. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application in 2025
Figure 31. Intravenous Immunoglobulin (IVIg) Sales by Company in 2025 (K Bottle)
Figure 32. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company in 2025
Figure 33. Intravenous Immunoglobulin (IVIg) Revenue by Company in 2025 ($ millions)
Figure 34. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company in 2025
Figure 35. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Intravenous Immunoglobulin (IVIg) Sales 2021-2026 (K Bottle)
Figure 38. Americas Intravenous Immunoglobulin (IVIg) Revenue 2021-2026 ($ millions)
Figure 39. APAC Intravenous Immunoglobulin (IVIg) Sales 2021-2026 (K Bottle)
Figure 40. APAC Intravenous Immunoglobulin (IVIg) Revenue 2021-2026 ($ millions)
Figure 41. Europe Intravenous Immunoglobulin (IVIg) Sales 2021-2026 (K Bottle)
Figure 42. Europe Intravenous Immunoglobulin (IVIg) Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales 2021-2026 (K Bottle)
Figure 44. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue 2021-2026 ($ millions)
Figure 45. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2025
Figure 46. Americas Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2021-2026)
Figure 47. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026)
Figure 48. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2026)
Figure 49. United States Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Region in 2025
Figure 54. APAC Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2021-2026)
Figure 55. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026)
Figure 56. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2026)
Figure 57. China Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 61. India Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2025
Figure 65. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2021-2026)
Figure 66. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026)
Figure 67. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2026)
Figure 68. Germany Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 69. France Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2026)
Figure 76. Egypt Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin (IVIg) in 2026
Figure 82. Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
Figure 83. Industry Chain Structure of Intravenous Immunoglobulin (IVIg)
Figure 84. Channels of Distribution
Figure 85. Global Intravenous Immunoglobulin (IVIg) Sales Market Forecast by Region (2027-2032)
Figure 86. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Intravenous Immunoglobulin (IVIg)
Figure 2. Intravenous Immunoglobulin (IVIg) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate 2021-2032 (K Bottle)
Figure 7. Global Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Intravenous Immunoglobulin (IVIg) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Intravenous Immunoglobulin (IVIg) Sales Market Share by Country/Region (2025)
Figure 10. Intravenous Immunoglobulin (IVIg) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of IVIg Liquid
Figure 12. Product Picture of IVIg Powder
Figure 13. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2026
Figure 14. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Low Concentration
Figure 16. Product Picture of Medium Concentration
Figure 17. Product Picture of High Concentration
Figure 18. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Treatment Setting in 2026
Figure 19. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Treatment Setting (2021-2026)
Figure 20. Product Picture of Acute Therapy
Figure 21. Product Picture of Maintenance Therapy
Figure 22. Product Picture of Critical Care
Figure 23. Intravenous Immunoglobulin (IVIg) Consumed in Immunodeficiency
Figure 24. Global Intravenous Immunoglobulin (IVIg) Market: Immunodeficiency (2021-2026) & (K Bottle)
Figure 25. Intravenous Immunoglobulin (IVIg) Consumed in Autoimmune Disease
Figure 26. Global Intravenous Immunoglobulin (IVIg) Market: Autoimmune Disease (2021-2026) & (K Bottle)
Figure 27. Intravenous Immunoglobulin (IVIg) Consumed in Acute Infection
Figure 28. Global Intravenous Immunoglobulin (IVIg) Market: Acute Infection (2021-2026) & (K Bottle)
Figure 29. Global Intravenous Immunoglobulin (IVIg) Sale Market Share by Application (2025)
Figure 30. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application in 2025
Figure 31. Intravenous Immunoglobulin (IVIg) Sales by Company in 2025 (K Bottle)
Figure 32. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company in 2025
Figure 33. Intravenous Immunoglobulin (IVIg) Revenue by Company in 2025 ($ millions)
Figure 34. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company in 2025
Figure 35. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Intravenous Immunoglobulin (IVIg) Sales 2021-2026 (K Bottle)
Figure 38. Americas Intravenous Immunoglobulin (IVIg) Revenue 2021-2026 ($ millions)
Figure 39. APAC Intravenous Immunoglobulin (IVIg) Sales 2021-2026 (K Bottle)
Figure 40. APAC Intravenous Immunoglobulin (IVIg) Revenue 2021-2026 ($ millions)
Figure 41. Europe Intravenous Immunoglobulin (IVIg) Sales 2021-2026 (K Bottle)
Figure 42. Europe Intravenous Immunoglobulin (IVIg) Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales 2021-2026 (K Bottle)
Figure 44. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue 2021-2026 ($ millions)
Figure 45. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2025
Figure 46. Americas Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2021-2026)
Figure 47. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026)
Figure 48. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2026)
Figure 49. United States Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Region in 2025
Figure 54. APAC Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2021-2026)
Figure 55. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026)
Figure 56. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2026)
Figure 57. China Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 61. India Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2025
Figure 65. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2021-2026)
Figure 66. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026)
Figure 67. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2026)
Figure 68. Germany Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 69. France Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2026)
Figure 76. Egypt Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Intravenous Immunoglobulin (IVIg) Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin (IVIg) in 2026
Figure 82. Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
Figure 83. Industry Chain Structure of Intravenous Immunoglobulin (IVIg)
Figure 84. Channels of Distribution
Figure 85. Global Intravenous Immunoglobulin (IVIg) Sales Market Forecast by Region (2027-2032)
Figure 86. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Application (2027-2032)
